Centessa Pharmaceuticals plc

Approval AI-extracted

cleminorexton (formerly ORX750) or ORX142

narcolepsy type 2

Countdown

1273days

Approval decision · ~ Dec 31, 2029 estimated

What's at stake A final FDA approval decision on cleminorexton (formerly ORX750) or ORX142 for narcolepsy type 2 is expected ~ Dec 31, 2029.

Primary source · SEC 8-K verified 14h ago

“upon the first U.S. FDA approval of cleminorexton (formerly ORX750) or ORX142 for the treatment of any indication prior to January 1, 2030”